By Yatharth Sharma With its launch earlier this year, billionaire Mark Cuban’s Cost Plus Drug Company has attracted widespread attention. Some researchers have claimed that the startup could save Medicare, the government insurance program mainly targeting the elderly, billions of dollars per year.1 In its current state, the United States drug market holds many drugs […]